{
  "id": 356,
  "text": "The 5-year cumulative risk of $\\mathrm { C I N } 2 +$ was $1 .0 \\%$ ( $9 5 \\%$ CI 0.2-4.6) and CIN3 was $0 \\%$ ( $9 5 \\%$ CI 0- 2.9) following a negative co-test at 6 and 24 months (69).Another study found that the 5-year $\\mathrm { C I N } 3 +$ risk after treatment for CIN2/3 for 1, 2 and 3 negative HPV testing or co-testing were $2 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The 5-year cumulative risk of $\\mathrm { C I N } 2 +$ was $1 .0 \\%$ ( $9 5 \\%$ CI 0.2-4.6) and CIN3 was $0 \\%$ ( $9 5 \\%$ CI 0- 2.9) following a negative co-test at 6 and 24 months (69).Another study found that the 5-year $\\mathrm { C I N } 3 +$ risk after treatment for CIN2/3 for 1, 2 and 3 negative HPV testing or co-testing were $2 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在接受宫颈上皮内瘤变治疗后，如果患者在6个月和24个月进行的HPV联合测试结果为阴性，那么其在未来5年内发生高级别宫颈上皮内瘤变（即CIN2+）的风险约为1.0%，而发生CIN3的风险为0%。如果针对CIN2/3进行了治疗后，患者在1次、2次或3次HPV测试中结果均为阴性，那么其5年后发生CIN3+的风险可能略高。根据不同研究，存在一定变异，但总体来说风险相对较低。定期随访可以帮助及时发现和处理潜在的风险。",
  "query": "接受宫颈上皮内瘤变治疗后，进行1次、2次或3次HPV测试或并验阴性，其5年后发生高级别宫颈上皮内瘤变的风险是多少？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 接受宫颈上皮内瘤变治疗后，进行1次、2次或3次HPV测试或并验阴性，其5年后发生高级别宫颈上皮内瘤变的风险是多少？\n\n<reference text>: The 5-year cumulative risk of $\\mathrm { C I N } 2 +$ was $1 .0 \\%$ ( $9 5 \\%$ CI 0.2-4.6) and CIN3 was $0 \\%$ ( $9 5 \\%$ CI 0- 2.9) following a negative co-test at 6 and 24 months (69).Another study found that the 5-year $\\mathrm { C I N } 3 +$ risk after treatment for CIN2/3 for 1, 2 and 3 negative HPV testing or co-testing were $2 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在接受宫颈上皮内瘤变治疗后，如果患者在6个月和24个月进行的HPV联合测试结果为阴性，那么其在未来5年内发生高级别宫颈上皮内瘤变（即CIN2+）的风险约为1.0%，而发生CIN3的风险为0%。如果针对CIN2/3进行了治疗后，患者在1次、2次或3次HPV测试中结果均为阴性，那么其5年后发生CIN3+的风险可能略高。根据不同研究，存在一定变异，但总体来说风险相对较低。定期随访可以帮助及时发现和处理潜在的风险。"
}